Showing results (341-350 of 352) with videos related to

Sort By:
Pageof 36
Cancer Chemotherapy and Pharmacology|January 27, 1998
All-trans-retinoic acid modulation of drug-metabolizing enzyme activities: investigation with selective metabolic drug probesA Adedoyin, D D Stiff, D C Smith, et al.
Neuroscience|June 5, 2007
Cortical edema in moderate fluid percussion brain injury is attenuated by vagus nerve stimulationR W Clough, S L Neese, L K Sherill, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|June 26, 1998
Cerebral oxygenation during paediatric cardiac surgery: identification of vulnerable periods using near infrared spectroscopyP E Daubeney, D C Smith, S N Pilkington, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 17, 2022
FIGHT-101, a first-in-human study of potent and selective FGFR 1-3 inhibitor pemigatinib in pan-cancer patients with FGF/FGFR alterations and advanced malignanciesV Subbiah, N O Iannotti, M Gutierrez, et al.
Radiology|April 1, 1987
Development and implementation of a quality assurance program for mammographyE S de Paredes, A B Frazier, G D Hartwell, et al.
The American Journal of Tropical Medicine and Hygiene|March 1, 1997
First clinical experiences with a new ovine Fab Echis ocellatus snake bite antivenom in Nigeria: randomized comparative trial with Institute Pasteur Serum (Ipser) Africa antivenomW P Meyer, A G Habib, A A Onayade, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1986
A randomized comparison of tamoxifen with surgical oophorectomy in premenopausal patients with advanced breast cancerR B Buchanan, R W Blamey, K R Durrant, et al.
Cancer Research|May 1, 1992
Modulation of O6-alkylguanine-DNA alkyltransferase-mediated carmustine resistance using streptozotocin: a phase I trialT J Panella, D C Smith, S C Schold, et al.
Journal of the National Cancer Institute|December 2, 1992
High-dose oral tamoxifen, a potential multidrug-resistance-reversal agent: phase I trial in combination with vinblastineD L Trump, D C Smith, P G Ellis, et al.
The Journal of Urology|December 23, 2000
Combination cisplatin, 5-fluorouracil and radiation therapy for locally advanced unresectable or medically unfit bladder cancer cases: a Southwest Oncology Group StudyM H Hussain, T R Glass, J Forman, et al.
Pageof 36